Header cover image

Canadian (TSX) Pharma Industry Analysis

UpdatedJun 16, 2024
DataAggregated Company Financials
Companies85
  • 7D-7.3%
  • 3M-16.1%
  • 1Y31.1%
  • YTD9.5%

Over the last 7 days, the Pharma industry has dropped 7.3%, driven by a pullback from Curaleaf Holdings of 11%. This takes the industry's 12 month performance to a gain of 31%. Looking forward, earnings are forecast to grow by 72% annually.

Industry Valuation and Performance

Has the Canadian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 16 Jun 2024CA$19.3bCA$11.8b-CA$2,769,898,710.4213.2x-7x1.6x
Tue, 14 May 2024CA$24.6bCA$11.9b-CA$3,392,450,017.1414.2x-7.3x2.1x
Thu, 11 Apr 2024CA$25.6bCA$12.0b-CA$3,493,375,864.239.4x-7.3x2.1x
Sat, 09 Mar 2024CA$19.8bCA$11.9b-CA$3,898,781,168.647.5x-5.1x1.7x
Mon, 05 Feb 2024CA$24.8bCA$12.4b-CA$6,728,600,976.009.1x-3.7x2x
Wed, 03 Jan 2024CA$17.7bCA$12.3b-CA$6,728,092,938.009.3x-2.6x1.4x
Fri, 01 Dec 2023CA$17.9bCA$12.4b-CA$6,775,870,288.008.7x-2.6x1.4x
Sun, 29 Oct 2023CA$14.9bCA$12.5b-CA$7,382,124,790.0011x-2x1.2x
Tue, 26 Sep 2023CA$20.3bCA$12.9b-CA$7,879,381,525.0013.9x-2.6x1.6x
Thu, 24 Aug 2023CA$13.9bCA$13.0b-CA$8,056,604,126.0015.5x-1.7x1.1x
Sat, 22 Jul 2023CA$14.9bCA$13.2b-CA$9,710,742,156.0012.2x-1.5x1.1x
Mon, 19 Jun 2023CA$14.7bCA$13.2b-CA$9,390,780,770.0012.5x-1.6x1.1x
Wed, 17 May 2023CA$14.8bCA$13.3b-CA$10,213,275,744.0010.1x-1.4x1.1x
Fri, 14 Apr 2023CA$15.5bCA$13.2b-CA$9,924,561,603.0010.1x-1.6x1.2x
Sun, 12 Mar 2023CA$18.9bCA$13.9b-CA$10,628,254,814.008.7x-1.8x1.4x
Tue, 07 Feb 2023CA$20.5bCA$13.6b-CA$10,158,056,415.0011x-2x1.5x
Thu, 05 Jan 2023CA$20.3bCA$13.6b-CA$10,117,950,152.0013.4x-2x1.5x
Sat, 03 Dec 2022CA$33.3bCA$13.6b-CA$10,188,493,690.0016.8x-3.3x2.5x
Mon, 31 Oct 2022CA$27.3bCA$13.4b-CA$9,379,847,292.008.9x-2.9x2x
Wed, 28 Sep 2022CA$24.7bCA$13.5b-CA$9,408,449,706.0011.2x-2.6x1.8x
Fri, 26 Aug 2022CA$32.7bCA$13.0b-CA$8,945,641,541.0013.1x-3.7x2.5x
Sun, 24 Jul 2022CA$29.4bCA$12.2b-CA$5,866,752,238.0011.6x-5x2.4x
Tue, 21 Jun 2022CA$28.1bCA$12.2b-CA$5,809,126,081.008.2x-4.8x2.3x
Thu, 19 May 2022CA$31.8bCA$12.0b-CA$5,663,879,448.009.6x-5.6x2.6x
Sat, 16 Apr 2022CA$40.8bCA$11.6b-CA$4,671,784,119.0012.3x-8.7x3.5x
Mon, 14 Mar 2022CA$39.3bCA$10.9b-CA$4,382,393,107.0012.4x-9x3.6x
Wed, 09 Feb 2022CA$49.8bCA$10.9b-CA$4,913,249,538.0012.9x-10.1x4.6x
Fri, 07 Jan 2022CA$51.1bCA$10.9b-CA$4,962,809,644.0013.3x-10.3x4.7x
Sun, 05 Dec 2021CA$55.4bCA$10.9b-CA$4,789,068,487.0014.8x-11.6x5.1x
Tue, 02 Nov 2021CA$59.3bCA$10.1b-CA$4,801,163,875.0015.9x-12.4x5.9x
Thu, 30 Sep 2021CA$66.6bCA$10.4b-CA$4,904,507,546.0018.7x-13.6x6.4x
Sat, 28 Aug 2021CA$69.1bCA$10.2b-CA$6,616,236,433.2721.4x-10.4x6.8x
Sun, 04 Jul 2021CA$83.0bCA$10.2b-CA$6,613,771,569.2724.2x-12.5x8.1x
Price to Earnings Ratio

-12.5x


Total Market Cap: CA$83.0bTotal Earnings: -CA$6,613,771,569.27Total Revenue: CA$10.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Pharma Industry Price to Earnings3Y Average -5.6x202220232024
Current Industry PE
  • Investors are pessimistic on the Canadian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 2.8x is higher than the industry's current PS ratio of 1.6x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Revenues for these companies have grown 4.9% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Canadian Healthcare industry?

CA Market-2.18%
Healthcare-4.07%
Pharma-7.25%
Pharma-7.25%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
WEED Canopy GrowthCA$9.993.7%
+CA$27.4m		20.4%PS2.6x
NGEN NervGen PharmaCA$2.3216.0%
+CA$22.4m		38.9%PB8.6x
GRIN Grown Rogue InternationalCA$0.94-1.1%
CA$7.4m		382.1%PE38.8x
NRX NurExone BiologicCA$0.5612.0%
+CA$4.0m		154.5%PB7.5x
AVCN AvicannaCA$0.2817.0%
+CA$3.9m		-9.8%PS1.2x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

VPH

CA$0.11

Valeo Pharma

7D

37.5%

1Y

-71.8%

TRUL

CA$11.68

Trulieve Cannabis

7D

-7.3%

1Y

121.2%

Trulieve Cannabis Corp.'s (CSE:TRUL) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Jun 15
Trulieve Cannabis Corp.'s (CSE:TRUL) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

WEED

CA$9.99

Canopy Growth

7D

3.7%

1Y

20.4%

Some Confidence Is Lacking In Canopy Growth Corporation (TSE:WEED) As Shares Slide 26%

Jun 15
Some Confidence Is Lacking In Canopy Growth Corporation (TSE:WEED) As Shares Slide 26%

CURA

CA$5.50

Curaleaf Holdings

7D

-11.0%

1Y

34.5%

Some Confidence Is Lacking In Curaleaf Holdings, Inc. (TSE:CURA) As Shares Slide 27%

Jun 14
Some Confidence Is Lacking In Curaleaf Holdings, Inc. (TSE:CURA) As Shares Slide 27%

PLTH

CA$0.66

Planet 13 Holdings

7D

-13.2%

1Y

-9.6%

NRX

CA$0.56

NurExone Biologic

7D

12.0%

1Y

154.5%

We're Keeping An Eye On NurExone Biologic's (CVE:NRX) Cash Burn Rate

Jun 12
We're Keeping An Eye On NurExone Biologic's (CVE:NRX) Cash Burn Rate

NGEN

CA$2.32

NervGen Pharma

7D

16.0%

1Y

38.9%

We're Interested To See How NervGen Pharma (CVE:NGEN) Uses Its Cash Hoard To Grow

Jun 11
We're Interested To See How NervGen Pharma (CVE:NGEN) Uses Its Cash Hoard To Grow

TSND

CA$1.85

TerrAscend

7D

-7.5%

1Y

-14.7%

CL

CA$2.21

Cresco Labs

7D

-7.9%

1Y

-0.5%

GTII

CA$15.45

Green Thumb Industries

7D

-8.0%

1Y

57.3%

GRIN

CA$0.94

Grown Rogue International

7D

-1.1%

1Y

382.1%

AVCN

CA$0.28

Avicanna

7D

17.0%

1Y

-9.8%

CRON

CA$3.25

Cronos Group

7D

-3.8%

1Y

45.1%

We're Interested To See How Cronos Group (TSE:CRON) Uses Its Cash Hoard To Grow

May 31
We're Interested To See How Cronos Group (TSE:CRON) Uses Its Cash Hoard To Grow

VRNO

CA$4.40

Verano Holdings

7D

-14.6%

1Y

17.3%

AYUR

CA$0.05

Ayurcann Holdings

7D

42.9%

1Y

-16.7%

RX

CA$9.51

BioSyent

7D

3.6%

1Y

32.1%